Fasken is a leading Canadian law firm with more than 700 lawyers and 10 offices on four continents. Clients rely on us for practical, innovative and cost-effective legal services. In the Life Sciences sector, we assist clients to solve their most complex business, litigation and regulatory compliance challenges. Offering exceptional value and putting clients at the centre of all we do is the key foundation of our firm. For additional information, please visit the firm’s website at fasken.com.
As the number of states legalizing cannabis for medical and adult use increases, there is growing disparity between federal and state laws concerning controlled substances. Businesses involved in the legal cultivation, processing, and distribution of cannabis, as well as those providing ancillary services, face an array of legal issues, including banking, regulatory compliance, branding and IP, federal taxation, corporate transactions and dispute resolution.
Members of Akerman's Cannabis Practice understand the complex legal and business issues impacting companies operating in this sector and we have the depth of experience and national reach necessary to help clients meet their business objectives. Our team monitors notable industry trends and legislative developments to provide timely guidance to clients seeking to navigate the maze of often-conflicting federal, state, and local laws and regulations governing cannabis.
Jean-Raphaël Champagne advises clients on issues related to commercial, regulatory and competition law. He assists a wide variety of players in the technology and life sciences sectors. He has extensive experience drafting and reviewing contracts, with respect to regulatory compliance with Health Canada and the rules governing advertising and ethical standards applicable to the pharmaceutical and cannabis industries.
Jean-Raphaël advises clients on the complex regulatory framework applicable to the cannabis market. He is often asked by the press to comment on various aspects of cannabis law in Canada.
He has participated in many start-ups in several high-technology sectors. In large transactions, he also assists clients with strategic aspects and issues arising from competition law.
Mr. Champagne is co-author of “The Pharma Legal Handbook – Canada”, which contains an entire chapter on commercialization of medical cannabis.
Josh Mandell is a member of Akerman’s national Cannabis Practice, which provides counsel to clients on the legal and business issues impacting companies with interests in the legal cannabis sectors. He counsels clients seeking to apply for cannabis licenses and advises investors and industry participants on regulatory compliance and litigation issues. He regularly speaks on cannabis law-related topics at industry-sponsored events and seminars.
Josh also has broad litigation experience in business and real estate disputes, including breach of contract matters, fraud claims, lender liability issues, and business torts. He represents financial institutions, secured lenders, commercial landlords, property owners, and real property receivers in real estate litigation. Josh also has extensive experience resolving matters in state and federal court through arbitration.